DaVita Inc.
DaVita Inc.
Your view on DVA
Overview
What the company does, where it operates, and who runs it.
About DaVita Inc.
- Industry
- Medical - Care Facilities
- Sector
- Healthcare
- CEO
- Javier J. Rodriguez
- Headquarters
- 2000 16th Street, Denver, CO, US
- Industry
- Medical - Care Facilities
- Sector
- Healthcare
- CEO
- Javier J. Rodriguez
- Headquarters
- 2000 16th Street, Denver, CO, US
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers.
It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services.
As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients.
Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Stock Data
Price chart, volume, and trading data.
What moved it
FRC Fair Value Algorithm
What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.
About this section
Fair value for DaVita Inc. from FRC's valuation model, read against the market price. DVA last traded at $174.22, 13.4× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for DaVita Inc.. Starting points for DaVita Inc.: P/E 13.4, EPS $14.41, beta 0.86 — an Medical - Care Facilities name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for DaVita Inc.. DaVita Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for DaVita Inc.. Trailing twelve-month EPS for DaVita Inc. stands at $14.41. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.
Current price
—
live quote
Analysts' target
$238.50
average of 6 firms, last 12 months
Analyst Ratings
- Strong Buy0
- Buy3
- Hold2
- Sell0
- Strong Sell0
Earnings Estimate
| EPS | Current QtrDec 2026 | Next QtrMar 2027 | Current YearFY Dec 2026 | Next YearFY Dec 2027 |
|---|---|---|---|---|
| Avg. estimate | $4.14 | $3.32 | $14.77 | $16.66 |
| Low estimate | $4.07 | $3.31 | $14.60 | $15.69 |
| High estimate | $4.21 | $3.33 | $15.10 | $17.68 |
| No. of analysts | 4 | 2 | 4 | 4 |
| Year-ago EPS | $3.40 | $2.87 | $9.84 | — |
| Growth | +21.8% | +15.5% | +50.1% | — |
Revenue Estimate
| Revenue | Current QtrDec 2026 | Next QtrMar 2027 | Current YearFY Dec 2026 | Next YearFY Dec 2027 |
|---|---|---|---|---|
| Avg. estimate | $3.65B | $3.53B | $14.19B | $14.66B |
| Low estimate | $3.64B | $3.52B | $14.09B | $14.42B |
| High estimate | $3.66B | $3.54B | $14.40B | $15.05B |
| No. of analysts | 3 | 1 | 5 | 5 |
| Year-ago revenue | $3.62B | $3.42B | $13.64B | — |
| Growth | +0.7% | +3.3% | +4.0% | — |
Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep from StreetInsider, Benzinga, Pulse 2.0; as of Nov 18, 2026. Not FRC research or a recommendation.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for DaVita Inc.. DaVita Inc. has reported as a listed company since 1995. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Peer companies
Market cap
- BAXBaxter International Inc.Medical - Instruments & Supplies$13.2B
- FMSFresenius Medical Care AG & Co. KGaAMedical - Care Facilities$11.7B
- RMTIRockwell Medical, Inc.Drug Manufacturers - Specialty & Generic$27M
More Medical - Care Facilities companies
- NLH.VNova Leap Health Corp.TSXV$20M
- NMSCANutrition Management Services CompanyOTC$285
- ACHCAcadia Healthcare Company, Inc.NASDAQ$3.6B
- ADUSAddus HomeCare CorporationNASDAQ$2.3B
- AGLAgilon Health, Inc.NYSE$2.0B
- AIDX20/20 Biolabs Inc.NASDAQ$2M
- AIRSAirSculpt Technologies, Inc.NASDAQ$52M
- AMBDAmerican Mobile Dental Corp.OTC$85,625
- AMNAMN Healthcare Services, Inc.NYSE$1.5B
- AMSAmerican Shared Hospital ServicesAMEX$7M
- AONCAmerican Oncology Network, Inc.OTC$351M
- ARDTArdent Health Partners, LLCNYSE$2.6B
ETFs holding DaVita Inc.
% of the fund
- RSPInvesco S&P 500 Equal Weight ETF$101.8B in assets0.19%
- VOOVanguard S&P 500 ETF$1.0T in assets0.01%
- VTIVanguard Total Stock Market ETF$689.2B in assets0.01%
- VBVanguard Small-Cap ETF$76.9B in assets0.08%
- OMAHVistaShares Target 15 Berkshire Select Income ETF$1.1B in assets4.30%
- LSATLeaderShares AlphaFactor Tactical Focused ETF$71M in assets2.99%
- CPAINorthern Lights Fund Trust III - Counterpoint Quantitative Equity ETF$550M in assets1.70%
- XHSState Street SPDR S&P Health Care Services ETF$245M in assets1.56%
Largest holders first, then the funds most concentrated in DVA.
Institutional Ownership
Which funds and firms own the stock.
About this section
Which institutions hold DaVita Inc., and how their positions are changing. At a $10.96B market value, institutional positions materially move DaVita Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by DaVita Inc. executives and directors. Shares of DaVita Inc. have traded between $115.39 and $179.60 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
About this section
U.S. Senate disclosures naming DaVita Inc.. DaVita Inc. is a $10.96B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.
House Trading
U.S. Representative disclosures filed under the STOCK Act.
About this section
U.S. House of Representatives disclosures naming DaVita Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for DaVita Inc.. Coverage tracks DaVita Inc. within Medical - Care Facilities (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of DaVita Inc.